| # | Drug | Count |
|---|---|---|
| 0 | TEPROTUMUMAB | 31 |
| 1 | METHIMAZOLE | 20 |
| 2 | PREDNISONE | 16 |
| 3 | METHYLPREDNISOLONE | 15 |
| 4 | ALEMTUZUMAB | 13 |
| 5 | PANTOPRAZOLE | 12 |
| 6 | PROPRANOLOL HYDROCHLORIDE | 12 |
| 7 | ERGOCALCIFEROL | 11 |
| 8 | LEVOTHYROXINE SODIUM | 11 |
| 9 | IBUPFROFEN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRACAINE HYDROCHLORIDE | 2 | 0.0150 |
| 1 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 2 | TEPROTUMUMAB | 31 | 0.0052 |
| 3 | TETRACAINE | 2 | 0.0051 |
| 4 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 5 | POLYVINYL ALCOHOL, POVIDONE | 9 | 0.0034 |
| 6 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 2 | 0.0033 |
| 7 | ARTIFICIAL TEARS | 8 | 0.0031 |
| 8 | METHIMAZOLE | 20 | 0.0025 |
| 9 | CARBAMIDE PEROXIDE | 1 | 0.0023 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 31 | 0.0052 |
| 1 | Plasma Volume Expander [EPC] | 8 | 0.0026 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 20 | 0.0021 |
| 3 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 13 | 0.0007 |
| 5 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 8 | Barbiturate [EPC] | 3 | 0.0003 |
| 9 | Ectoparasiticide [EPC] | 1 | 0.0003 |